Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment

Opinion
Video

Dr Christian Sandrock evaluates the impact of 2023 updated IDSA guidelines on treatment decisions for patients with antimicrobial resistant gram-negative infections and for patients with multidrug-resistant pathogens.

Recent Videos
Related Content
One Health, One Mission: Combatting AMR During US Antibiotic Awareness Week 2024

One Health, One Mission: Combatting AMR During US Antibiotic Awareness Week 2024

Sophia Abene
November 22nd 2024
Article
The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections

The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections

Christian Sandrock, MD, MPH, FCCP
November 8th 2023
Podcast
More Women Than Men Die After Staph Bacteremia

More Women Than Men Die After Staph Bacteremia

Kenneth Bender, PharmD, MA
November 17th 2024
Article
Expert Guidance on Managing Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in an Outpatient Setting

Expert Guidance on Managing Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in an Outpatient Setting

George Sakoulas, MD
November 7th 2023
Podcast
Hospital Report: Continued Reductions in Healthcare-Associated Infections

Hospital Report: Continued Reductions in Healthcare-Associated Infections

John Parkinson
November 15th 2024
Article
Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

Sophia Abene
November 11th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.